Congressional Oversight Provisions in the Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136)

April 17, 2020 (R46315)
Jump to Main Text of Report

Contents

Summary

The Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) includes a variety of oversight provisions designed to increase the information available to Congress regarding the federal government's implementation of the CARES Act and response to the COVID-19 pandemic more generally. Specifically, the CARES Act:

As agencies begin to implement the CARES Act and as the COVID-19 pandemic continues to develop, understanding the federal resources and information available can help Congress support both its own oversight activity and the consideration of potential future legislation to respond to COVID-19.

This report is a reference guide to the oversight mechanisms in the CARES Act and a launching pad for deeper consideration of oversight-related issues. This report complements other CRS products, such as a list of CRS experts covering issue areas related to other provisions of the CARES Act:


Introduction

The Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) was passed by Congress and signed into law by President Donald Trump on March 27, 2020. The CARES Act provides over $2 trillion in relief to individuals; businesses; state, local, and federal agencies; and industry sectors impacted by the COVID-19 pandemic and the government-led effort to limit its public health impact.1 Given the scope of the relief provided, the variety of new and existing programs that are to provide this aid, and the number of individuals and entities receiving aid, the administration of the CARES Act is likely to be a complicated and significant undertaking by executive branch agencies and non-federal partners. These complexities may be made even greater by both pressure to provide relief as swiftly as possible and unique logistical challenges posed by the ongoing public health emergency.

All of those factors make Congress's oversight role during the COVID-19 pandemic especially important and may make it more difficult for Congress to conduct timely oversight. Congress included a variety of oversight mechanisms in the CARES Act. In addition to requiring executive branch officers to submit reports on a variety of topics, provide notice before taking specified actions, and testify before certain committees, the CARES Act provides additional resources to the Government Accountability Office (GAO) and to Offices of Inspectors General (OIGs) that may have additional audit and investigative activity due to the CARES Act. In addition, the CARES Act creates three new oversight entities: a Congressional Oversight Commission, a Special Inspector General for Pandemic Recovery (SIGPR), and the Pandemic Recovery Accountability Committee (PRAC, a group of inspectors general). Each of those entities is empowered to provide oversight of significant aspects of the CARES Act.2

This report is a reference guide for congressional clients interested in understanding the congressional oversight tools built into the CARES Act. Oversight provisions are broadly organized into sections related to the nature of the oversight mechanism. Within each of these sections, agencies and entities are listed in alphabetical order. To the extent practicable, sections include citations to the CARES Act and to any other relevant laws and regulations.3

Scope of the Report

This report identifies selected provisions4 in the CARES Act that may facilitate Congress's ability to provide oversight of its implementation. Congress's authority to oversee the executive branch extends beyond these explicit requirements and includes many additional tools and requirements.5 The fact that many provisions of the CARES Act do not have explicit reporting requirements or other more formal oversight mechanisms does not prevent Congress from engaging in oversight activities related to those programs by seeking information from the executive branch, engaging with stakeholders, holding hearings, and using legislation to direct activities with specificity.

Requirements on agencies and entities are usually described in this report generally, with minimal discussion of detailed content requirements. The same is true for descriptions of new and altered programs. To the extent practicable, the text and footnotes of the report provide citations to the appropriate provisions of both the CARES Act and existing law to facilitate a more detailed review.

The report captures those oversight tools that pertain to inspectors general (who already have obligations to report to Congress in the Inspector General Act of 19786) and provisions that explicitly provide for congressional involvement. For instance, the CARES Act requires certain agencies to make information publicly available but does not explicitly direct that this information be submitted to Congress or its committees. Such provisions are not identified in this report but may nevertheless be referred to in practice as congressional reporting requirements.7

Provisions included in the CARES Act may trigger reporting of information under other statutes. Interactions between the CARES Act and current law are not covered in this report.

Oversight Provisions

The CARES Act contains a number of oversight provisions. These include:

Each aforementioned category is discussed in greater detail below.

Congressional Oversight Commission

Section 4020 establishes a legislative branch entity called the Congressional Oversight Commission to conduct oversight of the Department of the Treasury and Federal Reserve Board's economic relief activities under Title IV, Subtitle A (Coronavirus Economic Stabilization Act of 2020) of the CARES Act. The commission is similar in structure to the Congressional Oversight Panel created to participate in the oversight of the Troubled Asset Relief Program in 2008.8

The commission is composed of five members selected by the majority and minority leadership of the House and the Senate.9 The commission is empowered to request staff to be detailed from agencies and departments,10 hire experts and consultants,11 conduct hearings,12 and obtain information from agencies to support its oversight activities.13

The commission is required to report to Congress on the relevant activities of Treasury and the Federal Reserve Board,14 the impact of the programs on the financial well-being of the nation,15 whether required disclosures in the CARES Act provides market transparency,16 and the effectiveness of the Coronavirus Economic Stabilization Act of 2020 in minimizing costs and maximizing benefits for taxpayers.17

The first report of the commission is due within 30 days of Treasury and the Federal Reserve Board's first exercise of authority under the act. Additional reports are then due every 30 days thereafter.18 The commission terminates on September 30, 2025.19

Provisions Pertaining to Inspectors General20

Special Inspector General for Pandemic Recovery

Section 4018 establishes a Special Inspector General for Pandemic Recovery within the Treasury. The SIGPR is nominated by the President with the advice and consent of the Senate21 and may be removed from office according to Section 3(b) of the Inspector General Act of 1978.22 The SIGPR is tasked with conducting audits and investigations of the activities of the Treasury pursuant to the CARES Act, including the collection of detailed information regarding loans provided by Treasury.23

The SIGPR is empowered to hire staff24 and enter into contracts25 and has broadly the same authority and status as inspectors general under the Inspector General Act of 1978.26 The SIGPR is required to report to the "appropriate committees of Congress" within 60 days of Senate confirmation, and quarterly thereafter, on the activities of the office over the preceding three months, including detailed information on Treasury loan programs.27 The SIGPR terminates five years after the enactment of the CARES Act (i.e., March 27, 2025).28

Section 4027 appropriates a total of $500 billion to Treasury. Of that amount, Section 4018 directs that $25 million shall be made available to the SIGPR as no-year funds (i.e., funds that are available until expended).29

Pandemic Response Accountability Committee

Section 15010 establishes the PRAC within the CIGIE.30 The PRAC is directed to "promote transparency and conduct and support oversight" of the government's coronavirus response in order to "prevent and detect fraud, waste, abuse, and mismanagement" and "mitigate major risks that cut across program and agency boundaries."31 In addition, the PRAC is tasked with conducting oversight and audits of the coronavirus response as well as coordinating and supporting related oversight by inspectors general across the federal government.32

The PRAC is composed of the inspectors general of identified agencies as well as any other inspectors general for agencies involved at the coronavirus response as designated by the chairperson of the council.33 The CIGIE chairperson designates the PRAC chairperson.34 In addition, the PRAC is required to appoint an executive director selected in consultation with the majority and minority leadership of the House and the Senate.35 The PRAC has the same authority to conduct audits and investigations as inspectors general under the Inspector General Act of 1978.36

The PRAC is required to provide management alerts to the President and Congress on "management, risk, and funding" issues that may require immediate attention.37 The PRAC is also required to report to the President and Congress biannually with a summary of PRAC activity and, to the extent practicable, a quantification of the impact of tax expenditures in the CARES Act.38 Finally the PRAC is required to provide other reports and periodic updates to Congress as it considers appropriate.39

In addition, the PRAC is directed to establish and maintain a "user-friendly, public-facing website to foster greater accountability and transparency in the use of covered funds."40 The PRAC is required to post specified information, including agencies' use of funds provided in the act.41

The PRAC terminates on September 30, 2025.42 Section 15003 appropriates $80 million in no-year funds to support the activities of the PRAC.

The PRAC's organization and duties have similarities to those of the Recovery Accountability and Transparency Board that was established as part of the American Recovery and Reinvestment Act to conduct oversight of the use of funds in that act.43

Supplemental Appropriations and Additional Duties for Inspector General Offices

The CARES Act appropriates $148 million for established inspector general offices in addition to the $25 million for the SIGPR and $80 million for the PRAC discussed above. In total, therefore, the CARES Act provides $253 million to the inspector general community to oversee the federal government's coronavirus response.

Department of Agriculture
Department of Commerce
Department of Defense
Department of Education
Department of Health and Human Services
Department of Homeland Security
Department of Housing and Urban Development
Department of the Interior
Department of Justice
Department of Labor
Department of Transportation
Department of the Treasury
Department of Veterans Affairs
Small Business Administration

Provisions Pertaining to the Government Accountability Office

Title IX of Division B of the CARES Act, under the heading "Government Accountability Office," appropriates $20 million to GAO to conduct additional oversight and provide Congress with several reports. GAO is required to report to House and Senate Appropriations Committees within 90 days of enactment of the CARES Act with a spending plan for the funds and a timeline for audits and investigations.

GAO Reporting Requirements and Additional Responsibilities

Agency Reporting, Notice, and Consultation Requirements for Federal Entities and Sub-Entities

Architect of the Capitol

Armed Forces Retirement Home Trust Fund

Board of Governors of the Federal Reserve System

Centers for Disease Control and Prevention

Department of Commerce

Department of Defense

Department of Education

Department of Health and Human Services

Department of Homeland Security

Department of the Interior

Department of Labor

Department of State

Department of Transportation

Department of the Treasury

Department of Veterans Affairs

Election Assistance Commission

Federal Emergency Management Agency

General Services Administration

House of Representatives

Internal Revenue Service

Kennedy Center

Register of Copyrights

Small Business Administration

U.S. Patent and Trademark Office

General Provisions for Title VII of Division B

In addition to the requirements listed above for specific federal entities and sub-entities, Section 18109 authorizes that funds provided under Title VII of Division B may be used for personal services contracts72 with prior notification to the House and Senate Appropriations Committees. Title VII of Division B makes appropriations to the Department of the Interior, the Environmental Protection Agency, the Forest Service (Department of Agriculture), the Indian Health Service (HHS), the Agency for Toxic Substances and Disease Registry (HHS), the Institute of American Indian and Alaska Native Culture and Arts Development, the Smithsonian Institution, the Kennedy Center, and the National Foundation on the Arts and Humanities.

Requirements for Testimony

Chairman of the Board of Governors of the Federal Reserve System

Secretary of the Treasury

Author Contact Information

Ben Wilhelm, Analyst in Government Organization and Management ([email address scrubbed], [phone number scrubbed])
William T. Egar, Analyst in American National Government ([email address scrubbed], [phone number scrubbed])

Footnotes

1.

See CRS Report R46279, The Coronavirus Aid, Relief, and Economic Security (CARES) Act—Tax Relief for Individuals and Businesses, coordinated by Molly F. Sherlock; CRS Report R46298, The Coronavirus Relief Fund (CARES Act, Title V): Background and State and Local Allocations, by Grant A. Driessen; CRS Insight IN11282, COVID-19 and Direct Payments to Individuals: Summary of the 2020 Recovery Rebates/Economic Impact Payments in the CARES Act (P.L. 116-136), by Margot L. Crandall-Hollick; and CRS Report R46301, Title IV Provisions of the CARES Act (P.L. 116-136), coordinated by Andrew P. Scott. For questions about specific aspects of the CARES Act, see CRS Report R46299, Coronavirus Aid, Relief, and Economic Security (CARES) Act: CRS Experts, by William L. Painter and Diane P. Horn.

2.

For oversight provisions in other coronavirus response legislation, see CRS Insight IN11271, Congressional Oversight Provisions in P.L. 116-127, the Families First Coronavirus Response Act, by Ben Wilhelm; and CRS Insight IN11236, Oversight Provisions in H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act, by Ben Wilhelm.

3.

Unless otherwise indicated, citations are to the CARES Act.

4.

In addition to a manual review of the act, CRS also conducted keyword searches to identify requirements for agencies and other federal entities to notify, consult with, testify before, or otherwise report to Congress. Specifically, CRS searched for subsections of the CARES Act for (1) some variation on terms related to reporting requirements (including report, study, assess, audit, evaluate, communicate, strategy, plan, update, consult, brief, submit, transmit, notify, certify, update, and provide); and (2) references to Congress or its committees (including the terms Congress, House, Senate, and committee).

5.

See generally CRS Report RL30240, Congressional Oversight Manual, coordinated by Christopher M. Davis, Walter J. Oleszek, and Ben Wilhelm.

6.

5 U.S.C. Appendix.

7.

CRS Report R42490, Reexamination of Agency Reporting Requirements: Annual Process Under the GPRA Modernization Act of 2010 (GPRAMA), by Clinton T. Brass.

8.

See CRS Insight IN11304, COVID-19 Congressional Oversight Commission (COC), by Jacob R. Straus and William T. Egar.

9.

§4020(c).

10.

§4020(d)(3).

11.

§4020(d)(2).

12.

§4020(e)(1).

13.

§4020(e)(4).

14.

§4020(b)(2)(A)(i).

15.

§4020(b)(2)(A)(ii).

16.

§4020(b)(2)(A)(iii).

17.

§4020(b)(2)(A)(iv).

18.

§4020(b)(2)(B).

19.

§4020(f).

20.

For information about inspector general authorities and practices, see CRS Report R45450, Statutory Inspectors General in the Federal Government: A Primer, by Kathryn A. Francis.

21.

§4018(b).

22.

§4018(b)(3). See also 5 U.S.C. Appendix.

23.

§4018(c)(1).

24.

§4018(e)(1).

25.

§4018(e)(2).

26.

§4018(d)(1).

27.

§4018(f)(1).

28.

§4018(h).

29.

§4018(g).

30.

Title V of Division B, under the Heading "Pandemic Response Accountability Committee."

31.

§15010(b).

32.

§15010(d)(1)(A).

33.

§15010(c)(2).

34.

§15010(c)(1).

35.

§15010(c)(3)(B).

36.

§15010(e)(3)(A)(i).

37.

§15010(d)(2)(A)(i).

38.

§15010(d)(2)(B).

39.

§15010(d)(2)(A)(ii).

40.

§15010(g).

41.

§15011(b)(3). Section 15011(b)(1)(a) requires each agency to report "any obligation or expenditure of large covered funds" to the director of the Office of Budget and Management, the Bureau of the Fiscal Service, the PRAC, and the appropriate congressional committees.

42.

§15010(k).

43.

P.L. 111-5, §§1521 et seq.

44.

42 U.S.C. §254c-8 (Public Health Service Act, P.L. 78-410, as amended, §330H).

45.

42 U.S.C. §1396a note (Protecting Access to Medicare Act of 2014, P.L. 113-93, §223).

46.

This new provision is added to the Federal Food, Drug, and Cosmetic Act following Section 505F (21 U.S.C. §355g) by the CARES Act.

47.

42 U.S.C. §360fff-3.

48.

CARES Act, Title IV, Subtitle A (§§4001 et seq.).

49.

§19010(d).

50.

§19010(a)(1).

51.

§19010(c).

52.

Section 4026(b)(2)(B) requires that the Board of Governors of the Federal Reserve System publish these reports on its website within seven days of providing them to Congress.

53.

Specifically, 42 U.S.C. §254c-14.

54.

Specifically, 42 U.S.C. §254c.

55.

Specifically, 42 U.S.C. §247d-7e(c)(5)(A).

56.

Specifically, 42 U.S.C. §293d(d).

57.

Specifically, 42 U.S.C. §294o.

58.

Specifically, 42 U.S.C. §294c

59.

CRS was unable to find a statute of this name in enacted law. This may be a reference to pending legislation. See S. 2997 (116th Cong).

60.

Specifically, 42 U.S.C. §296e.

61.

New sections are added to Subchapter C of Chapter VII, which is codified as Title 21, Sections 379f et seq., of the U.S. Code.

62.

Under new sections, 744N(a) and 744N(b), of the Federal Food, Drug, and Cosmetics Act, respectively.

63.

Under a new section, 744N(d), of the Federal Food, Drug, and Cosmetics Act.

64.

Under a new section, 744N(c), of the Federal Food, Drug, and Cosmetics Act

65.

, as amended.

66.

The 2020 Recovery Rebates are refundable tax credit payments of up to $1,200 per adult and $500 per child provided in the CARES Act. See CRS Insight IN11282, COVID-19 and Direct Payments to Individuals: Summary of the 2020 Recovery Rebates/Economic Impact Payments in the CARES Act (P.L. 116-136), by Margot L. Crandall-Hollick. Section 2201(f)(1) provides additional transfer authority to move funds between the appropriations provided in Section 2201 for this purpose. Exercise of this authority requires notification to the House and Senate Appropriations Committees.

67.

Under Section 4026(b)(1)(B), the Secretary of the Treasury is required to publish these reports on the Treasury website within seven days of reporting to Congress. In addition, Section 4026(b)(1)(C) requires that Treasury publish a summary report including the same information online every 30 days.

68.

22 U.S.C. §286e-2.

69.

See §20003.

70.

41 U.S.C. §3304(a)(7)(A).

71.

50 U.S.C. §§1601 et seq.

72.

See 48 C.F.R. §37.104.